Tenofovir Alafenamide use in pregnant women with chronic hepatitis B virus infection: more data needed
- PMID: 35794305
- DOI: 10.1007/s12072-022-10376-x
Tenofovir Alafenamide use in pregnant women with chronic hepatitis B virus infection: more data needed
Comment on
-
Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy.Hepatol Int. 2022 Apr;16(2):211-253. doi: 10.1007/s12072-021-10285-5. Epub 2022 Feb 3. Hepatol Int. 2022. PMID: 35113359 Review.
References
Reference
-
- Kumar M, Abbas Z, Azami M, Belopolskaya M, Dokmeci AK, Ghazinyan H, Jia J, Jindal A, Lee HC, Lei W, Lim SG, Liu CJ, Li Q, Al Mahtab M, Muljono DH, Niriella MA, Omata M, Payawal DA, Sarin SK, Ségéral O, Tanwandee T, Trehanpati N, Visvanathan K, Yang JM, Yuen MF, Zheng Y, Zhou YH. Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy. Hepatol Int. 2022;16(2):211–53. - DOI
-
- Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy. World Health Organization, Geneva. 2020. Licence: CC BY-NC-SA 3.0 IGO
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
